Skip to main content
. 2022 Nov 24;14(23):5789. doi: 10.3390/cancers14235789

Table 1.

Patient Characteristics.

Patient Demographics Univariable Analysis
OS PFS
Parameter Categories Number (%), n = 46 (100%) HR (95% CI) p-Value HR (95%CI) p-Value
Age (years) Median (IQR) 61.8 (20.0) 1.0 (0.9, 1.0) 0.33 1.0 (1.00, 1.02) 0.89
Sex Male 26 (56.5) 0.7 (0.4, 1.4) 0.35 0.8 (0.4, 1.5) 0.46
Female 20 (43.5)
ECOG Performance Status 0 33 (71.7) 1.9 (0.9, 3.8) 0.073 1.9 (1.0, 3.7) 0.076
1 11 (23.9)
2 1 (2.2)
3 1 (2.2)
4 0 (0)
Sites of Metastasis at Baseline Liver 41 (89.1) 2.0 (0.6. 6.6) 0.25 1.3 (0.5, 3.6) 0.65
Lung 21 (47.5) 1.1 (0.6, 2.1) 0.8 0.9 (0.5, 1.7) 0.8
Brain 3 (6.5) 1.0 (0.3, 3.5) 0.95 0.7 (0.2, 2.4) 0.62
Bone 11 (23.9) 1.2 (0.6, 2.5) 0.6 1.3 (0.7, 2.6) 0.48
LN 14 (30.4) 2.1 (1.1, 4.2) 0.031 1.5 (0.8, 2.8) 0.24
Other 20 (43.5) 0.6 (0.3, 1.2) 0.13 0.7 (0.4, 1.3) 0.26
Liver Only 14 (30.4)
Liver + Extrahepatic. (vs. Liver Only) 28 (60.9) 1.4 (0.6, 3.2) 0.38 0.8 (0.4, 1.5) 0.48
Extrahepatic Only. (vs. Liver Only) 4 (8.7) 0.5 (0.1, 2.3) 0.36 0.7 (0.2, 2.6) 0.63